Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.6589
+0.0011 (0.17%)
At close: Oct 13, 2026, 4:00 PM EDT
0.6588
-0.0001 (-0.02%)
After-hours: Oct 13, 2026, 7:30 PM EDT
Standard BioTools Market Cap
Standard BioTools has a market cap or net worth of $258.67 million as of October 13, 2026. It is the 19,334th most valuable company in the world and the 3,362nd biggest in the United States. Its market cap has decreased by 47.10% in one year.
Market Cap
258.67M
Enterprise Value
-189.96M
1-Year Change
-47.10%
Global Rank
Country Rank
#3,362 United States
Category
ChartMarket Cap Chart
Since February 10, 2011, Standard BioTools's market cap has decreased from $260.60M to $258.67M, a decrease of -0.74%. That is a compound annual growth rate of -0.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 258.67M | -47.45% |
| Dec 31, 2025 | 492.20M | -24.45% |
| Dec 31, 2024 | 651.50M | 271.23% |
| Dec 29, 2023 | 175.50M | 89.12% |
| Dec 30, 2022 | 92.80M | -69.05% |
| Dec 31, 2021 | 299.80M | -32.58% |
| Dec 31, 2020 | 444.70M | 83.68% |
| Dec 31, 2019 | 242.10M | -28.58% |
| Dec 31, 2018 | 339.00M | 48.95% |
| Dec 29, 2017 | 227.60M | 7.36% |
| Dec 30, 2016 | 212.00M | -31.88% |
| Dec 31, 2015 | 311.20M | -67.35% |
| Dec 31, 2014 | 953.00M | -2.80% |
| Dec 31, 2013 | 980.50M | 174.19% |
| Dec 31, 2012 | 357.60M | 34.23% |
| Dec 30, 2011 | 266.40M | 2.23% |
| Feb 10, 2011 | 260.60M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CapsoVision | 339.32M |
| Quantum-Si incorporated | 308.63M |
| ClearPoint Neuro | 299.55M |
| Mobia Medical | 282.97M |
| InfuSystem Holdings | 268.68M |
| Treace Medical Concepts | 266.64M |
| Perspective Therapeutics | 259.12M |
| TriSalus Life Sciences | 246.30M |